Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1

Conditions

Multiple Myeloma 3Lymphoma 3Pancreatic Neoplasms 2Lung Neoplasms 2Hematologic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Glioma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Squamous Non Small Cell Lung Cancer 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 2Pemetrexed 2Docetaxel 2Carboplatin 2Bevacizumab 2trifluridine tipiracil drug combination 1trametinib 1spartalizumab 1sotorasib 1sintilimab 1palbociclib 1netrin-1 inhibitor NP137 1atezolizumab 1Panitumumab 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Irinotecan 1Injections 1Fluorouracil 1Everolimus 1Drug Therapy 1Cetuximab 1Afatinib 1ASP1570 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Solid Tumors × Afatinib × Clear all
NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡